Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Sarcoidosis
•
Pulmonology
Do you recommend avoidance of occupational/environmental exposures in patients with pulmonary sarcoidosis?
Related Questions
What serologic biomarkers do you send to assess for sarcoidosis at baseline and/or during flares, in patients where it may correlate with disease activity?
How do you approach medication management in biopsy-proven pulmonary sarcoidosis with disease stable for over 2 years on hydroxychloroquine and low dose prednisone?
How do you workup patients with neuropathy suspected to be secondary to sarcoid?
How do you approach management of adult patients with CVID and sarcoid-like syndrome?
Do you consider pulmonary hypertension related to sarcoidosis to be an indication to start steroids?
Is it safe to combine mycophenolate and adalimumab for management of pulmonary sarcoidosis in a patient that could not tolerate methotrexate?
How do you approach treating and monitoring sarcoidosis manifested by maxillary bone/teeth loss without other symptoms?
What is your approach to a patient who has a cardiac PET scan suggestive of sarcoid but no other supporting evidence of a diagnosis of sarcoid?
Do you consider skin involvement associated with tattoos to be a marker of disease activity and an indication to start treatment in a patient with sarcoidosis?
How would you manage asymptomatic osseous sarcoidosis of the lumbar spine without any other systemic involvement?
